申请人:——
公开号:US20030171403A1
公开(公告)日:2003-09-11
Compounds of formula (1), and pharmaceutically acceptable salts thereof, are capable of blockading voltage-dependent sodium channels and are useful in particular, in treating glaucoma and multiple sclerosis.
式(1)的化合物及其药学上可接受的盐能够阻断电压依赖性钠通道,并且在治疗青光眼和多发性硬化症方面具有用处。